You are here
- Home
- Total number of clinical trials
A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel-group Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Biomarkers of AZD3839 Including an Open-label Food Effect Group in Healthy Male and Female Volunteers of Non-childbearing Potential.
- Disease
- pharmacokinetics, safety
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jun 15, 2011
- Study Name
- D4080C00001
- Study Id
- D4080C00001
- ClinicalTrials.gov ID
- NCT01348737
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
